They have a huge pipeline and they're submitting ANDA's at a fast rate. Though the products don't have the same market size as IPCI's drugs, they are consistently growing and will most likely hit a profit next quarter for the first time. I got in at about $2.
News 
Market Data 
Discover 
AI
